Institut Du Cancer De Montpellier - Val D'aurelle
Clinical trials sponsored by Institut Du Cancer De Montpellier - Val D'aurelle, explained in plain language.
-
One-Time radiation during surgery could spare older breast cancer patients weeks of treatment
Disease control OngoingThis study tests a single dose of radiation given during breast-conserving surgery for women aged 60 and older with early-stage, low-risk breast cancer. The goal is to see if this shorter, targeted approach works as well as the standard 6.5 weeks of daily radiation. About 519 wom…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New combo therapy targets rare abdominal cancer
Disease control TerminatedThis study tests whether adding a special chemotherapy spray (PIPAC) directly into the abdomen to standard IV chemo can help people with a rare cancer of the belly lining (peritoneal mesothelioma) live longer. About 66 adults who have not had prior treatment will be randomly assi…
Phase: PHASE2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Extra radiation may keep breast cancer at bay
Disease control OngoingThis study looks at women with a very early breast cancer called DCIS. After surgery to remove the cancer, all women get whole-breast radiation. Half also get an extra radiation boost to the tumor area. The goal is to see if the boost lowers the chance of cancer coming back. Over…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New combo offers hope for Tough-to-Treat colon cancer
Disease control OngoingThis study tests whether combining two drugs (regorafenib and irinotecan) works better than regorafenib alone for people with advanced colorectal cancer that has stopped responding to standard treatments. About 377 adults with a specific genetic marker will take part. The goal is…
Phase: PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
New tracking tech aims to cut radiation side effects in prostate cancer
Disease control OngoingThis study tested a new radiation technique for prostate cancer that uses implanted sensors to track the prostate's position in real time. The goal was to see if this method causes fewer long-term side effects than standard image-guided radiation. 74 men with low- or intermediate…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
New MicroRNA test could spare thousands from unnecessary thyroid surgery
Diagnosis OngoingThis study aims to validate a microRNA signature that could better classify thyroid nodules with uncertain results from standard needle biopsies. Researchers will compare the test results with ultrasound and final surgical tissue analysis in 71 patients. If successful, this test …
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Jun 16, 2026 12:54 UTC
-
Yoga and physio may ease stress during cervical cancer radiation
Symptom relief OngoingThis study tests whether adding a special yoga and physiotherapy program to standard care can lower stress in women receiving brachytherapy for cervical cancer. About 98 women will take part. The program includes gentle movement and breathing exercises designed to be safe during …
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated Jun 16, 2026 12:49 UTC